JayDilipRamanMDFACS

Urology • Hershey, PA

Minimally Invasive Surgery, Surgical Oncology

Professor and Chair Department of Urology Penn State Health Milton S. Hershey Medical Center

Join to view full profile

Dr. Raman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Raman's full profile

Already have an account?

Office
500 University Dr
Hershey, PA 17033
Phone+1 717-531-8887

Fax+1 717-531-4475

Summary

Jay D. Raman, M.D., F.A.C.S. is currently Professor and Chair of the Department of Urology at the Penn State Health Milton S. Hershey Medical Center. He received his undergraduate degree from the Massachusetts Institute of Technology (MIT) and graduated AOA from Cornell University Medical College. Dr. Raman completed his urology residency at Cornell Medical Center followed by a fellowship in Laparoscopy and Robotics at the University of Texas Southwestern Medical Center in Dallas.

Dr. Raman’s clinical practice focuses on robotic-assisted surgery for prostate, kidney, ureteral, and adrenal cancers having completed over 2500 such cases. His basic science research centers on infectious complications following prostate needle biopsy as well biomarkers for urothelial cancer. His major clinical research efforts revolve around surgical complications as well as staging and therapy for urologic malignancies. To date, he has co-authored over 350 manuscripts, book chapters, and editorials and serves on the editorial board for 3 journals and as a reviewer for 12 journals.

Dr. Raman is currently Chair of the American Urologic Association (AUA) Office of Education, Past-President of the Mid-Atlantic AUA section, and Young Urology Representative to the American College of Surgeons.

Penn State Health : Prostate Cancer & Men's Health

Doctor turned patient, Brian Clark received life changing news when during a routine checkup led to a prostate cancer diagnosis. Dr. Jay Raman, Chair of the Dep

Penn State Health: Prostate Cancer & No Shave November

Prostate cancer is the second most common cancer in men in the United States. About one in eight men will be diagnosed with prostate cancer this year. A Dauphin

Penn State Health and Mid Penn Bank

Last month, we hosted our annual no-shave November show with Penn state health and Mid Penn bank. Every November, they team up to raise awareness for men's heal

Penn State Health : Dr. Raman

Dr. Jay Raman, Chair of the Department of Urology at Penn State Health and Aaron's surgeon joins us to discuss the importance of yearly screenings, who's at a h

Meet Prostate Cancer Survivor George Houck - Penn State Cancer Center

George Houck, Prostate Cancer Survivor * Dr. Jay Raman, Chair, Department of Urology Prostate cancer is one of the most common cancers found in men. It is secon

The Future of Urology Education: How to Stay Up to Date w/ Dr. Jay Raman | BackT

In this episode of BackTable Urology, Dr. Bagrodia and Dr. Jay Raman, the chair of urology at Penn State Health, discuss advancements and future directions of m

GU Podcast (2020): Chemo-ablation Of Upper-Tract Urothelial Carcinoma by AUAUniv

At the conclusion of this activity, participants will be able to: 1. Identify new technologies for the treatment of urothelial carcinoma and analyze the risks a

103020PennStateHealth.mp4

Penn State Health No Shave November 2020

Penn State Health Urology Residency Program

The Urology Residency is a five year program intended to develop a superb urologist who has as their primary concern the health and well-being of the patient...

Urology Teaching Collaborative | 6/4/20 | Dr. Jay Raman: Microhematuria Evaluati

Dr. Jay Raman from Penn State Health-Hershey's Department of Urology on Penn State Health-Hershey

Penn State Health Cancer Treatment and Research

Cancer is a diagnosis no one wants to hear. Fortunately, patients are living longer thanks to the advancement of treatment and research. On a special Good Day P

5.21.2020 Urology COViD Didactics - Evaluation of the Patient with MicroHematuri

Week 8 session 7 for Urology Collaborative Online Virtual Didactics (COViD) lecture series. Date: 5.21.2020 Topic: Evaluation of the Patient with MicroHematu...

No Shave November 2019 - Penn State Health

No-Shave November is a month-long journey during which participants forgo shaving and grooming in order to evoke conversation and raise cancer awareness. Pen...

Penn State Health - THIS is Heroism.

In the most challenging times, heroes emerge. As children our heroes wore capes and had superhuman powers. As adults, we've found that phenomenal strength, d...

Penn State Health: No Shave November, Prostate Cancer Prevention

During the month of November, men are asked to let their hair and beards grow to raise money and awareness in the fight against prostate cancer. On a special Go

Mid Penn Bank, Penn State Health 'No Shave November' campaign raises $60K

Last month, friends from Penn State Health and Mid Penn Bank teamed up to raise money and awareness for prostate cancer. On Thursday's Good Day PA, we learned t

What are some of the risk factors of prostate cancer? Penn State Cancer Institut

What are some of the risk factors of prostate cancer? Quick answers from our Penn State Cancer Institute experts! Dr. Jay Raman Professor & Chief, Division of U

When should men get screened for prostate cancer? - Penn State Cancer Institute

When should men get screened for prostate cancer? Quick answers from our Penn State Cancer Institute experts! Dr. Jay Raman Professor & Chief, Division of Urolo

No Shave November donations to Penn State Cancer Institute

As "No Shave November" comes to an end, Penn State Health and Mid Penn Bank share the results of a fundraising effort for prostate cancer research.

Penn State Health: 'Movember' & Prostate Cancer

Today is the start of "Movember." Doctors from Penn State Cancer Institute were on Good Day PA to talk about prostate cancer.

Penn State Health: New MRI Guided Fusion Prostate Biopsy

It's a new detection technique for Prostate Cancer. Dr. Jay Raman, Chief of Urology at Penn State Health was here to tell us all about the new technique!

Penn State Health: Prostate Cancer Prevention and Detection Special Part 1

In part one of this special edition of Good Day PA, we'll learn about a midstate man who discovered a rise in his PSA test numbers after being regularly tested

The Significance of Hematuria in Urothelial Carcinoma

Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with

What new prostate cancer research is being done at Penn State Hershey?

What new prostate cancer research Penn State Hershey working on? Jay D. Raman, M. D., Urologist, Penn State Cancer Institute

What happens after being diagnosed with prostate cancer?

Penn State Cancer Institute - What happens after being diagnosed with prostate cancer? Jay D. Raman, M. D. Urologist, Penn State Cancer Institute

Dr. Raman on Hematuria in Urothelial Cancer

Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with

AUAA... Episode 2 - Prostate Cancer - Penn State Health Milton S. Hershey Medica

Dr. Jay Raman, Chief, Division of Urology at Penn State Health answers questions in a Facebook Live interview. Answering when some men should start getting scre

Behind the Hands - Penn State Hershey Cancer Institute - Jay Raman, M.D.

Penn State Hershey - when choosing a surgeon, the technique - whether robotic or open surgery - doesn't matter as much as the experience of the surgeon and his

Clinical Expertise

Urologic oncology, Minimally invasive urologic surgery, Nephrectomy, Local Neoplasm Recurrence, Retrospective Studies, Kidney Neoplasms, Laparoscopy, Health outcomes research, Prognosis, Urologic Neoplasms, Adrenal disease, Prostatectomy, Biopsies, Combined modality therapy, Hydronephrosis, Neoplasm staging, Immunohistochemistry, Ureteroscopy, Lymph node excision, Logistic models, Testicular cancer, Bladder cancer, Kidney cancer, Robotic partial nephrectomy, Prostate cancer

Education & Training

University of Texas Southwestern Medical CenterFellowship, Minimally Invasive Urologic Surgery, 2007 - 2008
New York Presbyterian Hospital (Cornell Campus)Residency, Urology, 2003 - 2007
New York Presbyterian Hospital (Cornell Campus)Residency, Surgery, 2001 - 2003
Weill Cornell MedicineClass of 2001
Massachusetts Institute of TechnologyB.S., 1997

Certifications & Licensure

PA State Medical License 2008 - 2024
NY State Medical License 2003 - 2008
TX State Medical License 2007 - 2008
American Board of Urology Urology
American College of SurgeonsFellow
Endourology SocietyFellowship Certification
Society of Urologic OncologyMember

Awards, Honors, & Recognition

First Place 42nd Annual Ralph E. Hopkins Urology Seminar, 2023
Top Doctors Castle Connolly, 2020-2023
AUA Distinguished Service Nominee Mid-Atlantic Section of AUA, 2019
AUA Gold Cystoscope Award Nominee Mid-Atlantic AUA Section, 2017
Young Urologist of the Year American Urological Association, 2015
Best Reviewer of the Year Journal of Urology, 2014
Essay Contest (2nd prize) Endourology Society, 2008
Outstanding Resident Award Society of Laparoscopic Surgeons, 2007
Distinguished Housestaff Award New York Presbyterian Hospital, 2006
John W. Coleman Resident Teaching Award in Urology 2006
John Metcalf Polk Prize for Highest Academic Achievement 2001
E. Darracott Vaughan Jr. Prize for Excellence in Urology v 2001
Scholar Teagle Foundation, 2001
Alpha Omego Alpha (AOA) Medical Honor Society 1999
Join now to see all

Clinical Trials

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study Start of enrollment: 2017 Apr 04
Completed
Phase 3
Multi Institutional Study in Patient Presenting With Hematuria Start of enrollment: 2017 Mar 31
Active, not recruiting
Neoadjuvant Apalutamide (ARN509) and Radical Prostatectomy in Treatment of Intermediate to High Risk Prostate Cancer Start of enrollment: 2017 Jun 20
Completed
Phase 2
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Start of enrollment: 2018 Oct 15
Completed
Phase 2
STRATA: Safe Testing of Risk for AsymptomaTic MicrohematuriA Start of enrollment: 2019 Sep 11
Active, not recruiting
Not Applicable
A Phase 3 Single-Arm Study of UGN-102 for Treatment of Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer Start of enrollment: 2022 Mar 01
Active, not recruiting
Phase 3
Roles: Contact, Principal Investigator
ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study Start of enrollment: 2021 Mar 22
Recruiting
Phase 3
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

39 citations
Residual fragments after percutaneous nephrolithotomy: cost comparison of immediate second look flexible nephroscopy versus expectant management.
Jay D. Raman, Aditya Bagrodia, Karim Bensalah, Margaret S. Pearle, Yair Lotan
The Journal of Urology. 2010-01-01
9 citations
The Selection for Cytoreductive Nephrectomy (SCREEN) Score: Improving Surgical Risk Stratification by Integrating Common Radiographic Features.
E Jason Abel, Viraj A Master, Philippe E Spiess, Jay D Raman, Daniel D Shapiro
European Urology Oncology. 2024-04-01
198 citations
Robotic vs open radical cystectomy: prospective comparison of perioperative outcomes and pathological measures of early oncological efficacy.
Gerald J. Wang, Daniel A. Barocas, Jay D. Raman, Douglas S. Scherr
BJU International. 2007-09-20

Journal Articles

Original Contribution Mitotic Activity in Non-Invasive Papillary Urothelial Carcinoma: Its Value in Predicting Tumor Recurrence, and Comparison to the Contemporary Two...
Augustyna Gogoj, Suzanne B Merrill, Monika Joshi, Sheldon Holder, Joshua I Warrick, Matthew Kaag, Jay D Raman, Joseph Drabick, ScienceDirect
Predicted Versus Observed 30-Day Perioperative Outcomes Using the ACS NSQIP Surgical Risk Calculator in Patients Undergoing Partial Nephrectomy for Renal Cell Carcinoma
Brian M Blair, Jay D Raman, Matthew G Kaag, International Urology and Nephrology
TALL score for prediction of oncological outcomes after radical nephroureterectomy for high-grade upper tract urothelial carcinoma
Youssef RF, Krabbe LM, Shariat SF, Lotan Y, Sagalowsky AI, Raman J, Wood CG, Weizer A, Roscigno M, Montorsi F, Bolenz C, Remzi M, Bensalah K, Kassouf W, Margulis V, World J Urol, 1/1/2015
Lynch syndrome: a primer for urologists
Mork M, Hubosky SG, Roupret M, Margulis V, Raman J, Lotan Y, O'Brien T, You N, Sharait SF, Matin SF, J Urol, 1/1/2015
Volumetric changes following partial nephrectomy
Raman JD, Can J Urol, 1/1/2015
Systemic chemotherapy and radical nephroureterectomy
Jafri S and Raman JD, Int Urol Nephrol, 1/1/2015
Hospital readmission following urologic surgery
Raman JD, Can J Urol, 1/1/2015
Multi-Institutional Validation of the Predictive Value of KI-67 in Patients with High-Grade Urothelial Carcinoma of the Upper Urinary Tract
Krabbe LM, Bagrodia A, Haddad AQ, Kapur P, Khalil D, Hynan LS, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Rioux-Leclercq N, Haitel A, Roscigno M, Bolenz C, Bensa..., J Urol, 1/1/2014
Peri-procedural povidone-iodine rectal preparation reduces microorganism counts and infections complications following ultrasound-guided needle biopsy of the prostate
Gyorfi JR, Otteni C, Brown K, Patel A, Lehman K, Phillips BE, Dewan K, Kirimanjeswara G, Raman JD, World J Urol, 1/1/2014
Insulin-like Growth Factor Messenger RNA-binding Protein 3 Expression Helps Prognostication in Patients with Upper Tract Urothelial Carcinoma
Lee DJ, Xylinas E, Rieken M, Khani F, Klatte T, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Guo CC, Rioux-Leclercq N, Haitel A, Bolenz C, Bensalah K, Sagalowsky A..., Eur Urol, 1/1/2014
BAP1 Immunohistochemistry Predicts Outcomes in a Multi-Institutional Cohort with Clear Cell Renal Cell Carcinoma
Kapur P, Christie A, Raman JD, Then MT, Nuhn P, Buchner A, Bastian P, Seitz C, Shariat SF, Bensalah K, Rioux-Leclercq N, Xie XJ, Lotan Y, Margulis V, Brugarolas J, J Urol, 1/1/2014
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool
Xylinas E, Kluth L, Passoni N, Trinh QD, Rieken M, Lee RK, Fajkovic H, Novara G, Margulis V, Raman JD, Lotan Y, Roupret M, Aziz A, Fritsche HM, Weizer A, Martinez-Sala..., Eur Urol, 1/1/2014
Predictors of survival in patients with disease recurrence following radical nephroureterectomy
Kluth LA, Xylinas E, Kent M, Hagiwara M, Kikuchi E, Matsumoto K, Ikeda M, Dalpiaz O, Zigeuner R, Aziz A, Fritsche HM, Deliere A, Raman JD, Bensalah K, Al-Matar B, Gaki..., BJU Int, 1/1/2014
Upper Tract Urothelial Carcinoma Collaboration Impact of Distal Ureter Management on Oncologic Outcomes Following Radical Nephroureterectomy for Upper Tract Urothelial...
Xylinas E, Rink M, Cha EK, Clozel T, Lee RK, Fajkovic H, Comploj E, Novara G, Margulis V, Raman JD, Lotan Y, Kassouf W, Fritsche HM, Weizer A, Martinez-Salamanca JI, M..., Eur Urol, 1/1/2014
Considerations regarding active surveillance for small renal masses
Raman JD, Can J Urol, 1/1/2014
Editorial Comment from Dr Kaag and Dr Raman to Obesity and prognosis in muscle-invasive bladder cancer: the continuing controversy
Kaag MG, Raman JD, Int J Urol, 1/1/2014
Editorial Comment to Retreatment after percutaneous nephrolithotomy in the computed tomography era: long-term follow-up
Reynolds CR, Raman JD, Urology, 1/1/2014
Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomized, prospective, controlled multi-institutional trial
Eggener SE, Large MC, Gerber GS, Pettus J, Yossepowitch O, Smith ND, Kundu S, Kunnavakkam R, Zorn K, and Raman JD, BJU Int, 1/1/2013
Upper Tract Urothelial Carcinoma Collaboration (UTUCC) Gender-specific effect of smoking on upper tract urothelial carcinoma outcomes
Rink M, Xylinas E, Trinh QD, Lotan Y, Margulis V, Raman JD, Fisch M, Lee RK, Chun FK, Abdennabi J, Seitz C, Pycha A, Zlotta AR, Karakiewicz PI, Babjuk M, Scherr DS, Sh..., BJU Int, 1/1/2013
UTUC Collaboration Impact of renal function on eligibility for chemotherapy and survival in patients who have undergone radical nephro-ureterectomy
Xylinas E, Rink M, Margulis V, Clozel T, Lee RK, Comploj E, Novara G, Raman JD, Lotan Y, Weizer A, Roupret M, Pycha A, Scehrr DS, Seitz C, Ficarra V, Trinh QD, Karakie..., BJU Int, 1/1/2013
Conservative nephron-sparing treatment of upper-tract tumors
Smith P, Mandel J, and Raman JD, Curr Urol Reports, 1/1/2013
Significant variability in 10-year cumulative radiation exposure incurred on different surveillance regimens after surgery for pT1 renal cancers: yet another reason to...
Lin YK, Gettle L, and Raman JD, BJU Int, 1/1/2013
UTUC Collaboration Prediction of true nodal status in patients with pathologic lymph node negative upper tract urothelial carcinoma at radical nephroureterectomy
Xylinas E, Rink M, Margulis V, Faison T, Comploj E, Novara G, Raman JD, Lotan Y, Guillonneau B, Weizer A, Pycha A, Scherr DS, Seitz C, Sun M, Trinh QD, Karakiewicz PI,..., J Urol, 1/1/2013
French National Database on Upper Tract Tumors and the Upper Tract Urothelial Carcinoma Collaboration (UTUCC) Prediction of cancer-specific survival after radical neph...
Roupret M, Hupertan V, Seisen T, Colin P, Xylinas E, Yates DR, Fajkovic H, Lotan Y, Raman JD, Zigeuner R, Remzi M, Bolenz C, Novara G, Kassouf W, Ouzzane A, Rozet F, C..., J Urol, 1/1/2013
Upper Tract Urothelial Carcinoma Collaboration Impact of Smoking on Oncologic Outcomes of Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy
Rink M, Xylinas E, Margulis V, Cha EK, Ehdaie B, Raman JD, Chun FK, Matsumoto K, Lotan Y, Furberg H, Babjuk M, Pycha A, Wood CG, Karakiewicz PI, Fisch M, Scherr DS, Sh..., Eur Urol, 1/1/2013
Join now to see all

Books/Book Chapters

Prostate Cancer
Chapter: Indications for pelvic lymphadenectomy
Raman JD and Gherezghihir AElsevier-SaundersEdition 2nd,2015
Campbell-Walsh Urology
Chapter: Hematuria: Diagnosis and Management
Boorjian SA, Raman JD, Barocas DAElsevier-SaundersEdition 11th,2014
Clinical Management of Urolithiasis
Chapter: Acute Flank Pain
Rippel C and Raman JDSpringer-Verlag, Heidelberg, Berlin, Germany2012
Scar-LESS surgery
Chapter: Single port laparoscopy: Issues and Complications
Raman JDSpringer-Verlag, NY2012
Smith's Textbook of Endourology
Chapter: Physiologic effects of pneumoperitoneum
Raman JD and Cadeddu JAJohn Wiley and Sons, UKEdition 3rd,2010
AUA Update Series
Chapter: Management of stones in anomalous kidneys
Page 210 - 219Elliott VL, Clements T, Gettle L, and Raman JD2010
Evidence-based Urology
Chapter: Surgical management of ureteral stone disease
Raman JD and Pearle MSEditors: Dahm P and Dmochowski R.John Wiley and Sons, UK2010
Urinary Tract Stone Disease
Chapter: Shock wave lithotripsy for ureteral calculi
Raman JD and Pearle MSEditors: Rao NP, Preminger GM, and Kavanagh JP.2010
Cancer of the Testis
Chapter: Post-chemotherapy retroperitoneal lymph node dissection
Raman JD and Sheinfeld JEditors: Laguna MP, Albers P, Richie J, and Bokemeyer, C.Springer London Ltd,, UK2010
AUA Update Series
Chapter: Natural orifice transluminal endoscopic surgery: potential applications in urology
Page 150 - 155Messer J, Raman JD, Tracy CR, and Cadeddu JA2009
Last Minute Internal Medicine Review Book
Chapter: Urologic Disorders
Raman JD and Scherr DSEditors: Miksad R, DeLaMora P, and Meyer G.McGraw-Hill, NY2008
Join now to see all

Lectures

Evaluation and management of urinary tract bleeding: from asymptomatic microhematuria to intractable hemorrhagic cystitis
1/1/2015
Upper-tract Urothelial Carcinoma: controversies and considerations
Washington, DC - 1/1/2015
Surgical management of urothelial carcinoma with squamous differentiation
1/1/2014
Robotic surgery
Hershey, PA - 1/1/2014
Twenty-five years of urothelial cancer in Pennsylvania
Hershey, PA - 1/1/2014
Kidney Cancer, Reducing Cancer in our Community
Hershey, PA - 1/1/2014
Lasers, Laparoscopes, and Lithotvriptors: The science behind minimally invasive surgery
Charlottesville, VA - 1/1/2013
Contemporary outcomes of renal thermal ablation
Penn State Hershey Medical Center, Hershey, PA - 1/1/2013
Creating an infrastructure for comprehensive care of urologic diseases
Washington, DC - 1/1/2013
Prostate Cancer Take Home Highlights
San Diego, CA - 1/1/2013
Lasers, laparoscopes, and lithotripters: the science of minimally invasive surgery
Charlottesville, VA - 1/1/2013
Best of the American Urologic Association (AUA)
San Jose, CR - 1/1/2013
Infectious complications following prostate needle biopsy: an increasing problem with need for solutions
White Sulfur Springs, WV - 1/1/2013
Strategies to reduce infections following prostate needle biopsy
Penn State University, University Park, PA - 1/1/2013
Single port laparoscopic surgery in urology: setting Started
North Shore Center for Simulation and Innovation, Evanston, IL - 1/1/2011
Pitfalls for single site laparoscopic surgery
Washington, DC - 1/1/2011
Management of a rising PSA following surgery or radiotherapy for localized prostate cancer
State College, PA - 1/1/2011
Changes in urinary biomarkers of kidney injury following partial nephrectomy
Oakland, CA - 1/1/2011
Prostate cancer screening - making (some) sense out of the controversy
State College, PA - 1/1/2011
Invasive and non-invasive access considerations for robotic assisted urologic surgery
Penn State Hershey Medical Center, Hershey, PA - 1/1/2010
Single site laparoscopic surgery: fad or future
University of Miami School of Medicine, Miami, FL - 1/1/2010
Surveillance for management of the small renal mass
Farmington, PA - 1/1/2010
Why should we pursue LESS?
Chicago, IL - 1/1/2010
Access for LESS nephrectomy
Chicago, IL - 1/1/2010
LESS: Challenges, complications, and how to avoid them
San Francisco, CA - 1/1/2010
Join now to see all

Authored Content

Highlights from AUA 2023May 2023
AUA Hybrid Format SuccessMay 2022
Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Multi-Institutional Evaluation of the Prognostic Significance of EZH2 Expression in High-Grade Upper Tract Urothelial CarcinomaMay 2018
Join now to see all

Press Mentions

Health System, College of Medicine Elevate Urology to DepartmentMay 26th, 2021
Many Men Ignore Testicular Cancer Symptoms for MonthsJuly 5th, 2016
Detecting and Treating Urologic Cancers with Penn State Hershey Cancer InstituteSeptember 8th, 2015
Join now to see all

Grant Support

The Efficacy and Safety of UGN-102 as a Primary Chemoablation Therapy in Patients With LG NMIBC at Intermediate Risk of RecurrenceUrogen Pharma Ltd2019–2021
The CXBladder Hematuria Clinical Utility StudyPacific Edge Biotechnologies2019–2021
A Phase 3 Multicenter Trial Evaluating the Efficacy and Safety of Instillation of Mitogel on Ablation of Urothelial Carcinoma Lesions in the Upper Urinary TractUrogen Pharma Ltd2017–2020
Multi-Institutional Study To Evaluate DNA Methylation Markers For Detection Of Primary Bladder Cancers In Urine Samples From a Cohort Of Patients With HematuriaMDXHealth Inc.2017–2019
Association of metabolic syndrome with pathologic characteristics of kidney cancerPenn State Kidney Cancer Fund2015–2019
Impact of low dose naltrexone on in vitro and in vivo prostate cancer growthKen and Bonnie Shockey Fund2014–2019
Molecular profiling of high risk bladder cancer to predict BCG responsivenessAlbert Foundation2016–2018
Nanojacket delivery of novel antibioticsPenn State Clinical Translational Science Institute (CTSI)2015–2017